# The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo

> **NCT03247400** · PHASE1,PHASE2 · COMPLETED · sponsor: **Nicolaus Copernicus University** · enrollment: 24 (actual)

## Conditions studied

- Non-segmental Vitiligo

## Interventions

- **DRUG:** 1% simvastatin-acid sodium salt ointment
- **DRUG:** 1% atorvastatin calcium salt ointment

## Key facts

- **NCT ID:** NCT03247400
- **Lead sponsor:** Nicolaus Copernicus University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-01
- **Primary completion:** 2018-12-31
- **Final completion:** 2019-04-30
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2020-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03247400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03247400, "The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03247400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*